LIGHTCYCLER MRSA ADVANCED TEST FOR USE WITH THE LIGHTCYCLER 2.0 INSTRUMENT 05352894190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01 report with the FDA on 2012-04-11 for LIGHTCYCLER MRSA ADVANCED TEST FOR USE WITH THE LIGHTCYCLER 2.0 INSTRUMENT 05352894190 manufactured by Roche Molecular Systems.

Event Text Entries

[2590609] A customer in (b)(6) filed a complaint alleging that a (b)(6) result was generated when using the lightcycler (b)(9) advanced test for use with the lightcycler 2. 0 ce-ivd ((b)(4)). The customer sent the sample to an associated reference lab and the sample generated the following results: (b)(6). The isolate is being returned for investigative testing / sequencing analysis. It was stated in the case that there was no change made to patient treatment and no patient harm due to the generation of the (b)(6) result in question
Patient Sequence No: 1, Text Type: D, B5


[9852002] Upon investigation there was no internal nonconformances generated for kit batch p09467. Qc release data for the kit batch met specifications. No product or batch non-conformance was identified. No trend was observed on the complaint issue. No testing of the retention kit was performed as the sequencing of the returned patient sample indicated: the customer-returned isolate was determined to be (b)(6). The re sequence that was obtained lacks an (b)(6) advanced test upstream primer binding site, and therefore cannot be detected. As indicated in the lightcycler mrsa advanced test for use with the lightcycler 2. 0 instrument package insert in the procedural limitations section: interpretation of results: a (b)(6) lightcycler mrsa advanced test does not preclude (b)(6) nasal colonization. Quality control: to date, seven (b)(6) have been distinguished, and several variants of these (b)(6) types have been described. The lightcycler mrsa advanced test is based on a proprietary detection system which is able to detect (b)(6) strains with different molecular sequences in the vicinity surrounding the (b)(6) cassette with the orfx gene. The re types that have been shown to be detected by the lightcycler mrsa test include (b)(6). In addition, sequence analysis of type (b)(6) has shown 100% homology to the primers and probes used in the lightcycler 2. 0 mrsa advanced test. Procedural limitations: though rare, mutations or polymorphisms within the region of the bacterial genome covered by the test's primers and/or probe may impair detection. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[9950222] No conclusion can be drawn at this time as the investigation into this issue is ongoing. The conclusion of the investigation will be submitted through a follow-up report. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2012-00017
MDR Report Key2526636
Report Source01
Date Received2012-04-11
Date of Report2012-05-11
Date of Event2012-01-27
Date Mfgr Received2012-05-11
Date Added to Maude2012-09-11
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA0
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLIGHTCYCLER MRSA ADVANCED TEST FOR USE WITH THE LIGHTCYCLER 2.0 INSTRUMENT
Generic NameREAL TIME NUCLEIC ACID AMPLIFICATION SYSTEM FOR MRSA
Product CodeJJF
Date Received2012-04-11
Catalog Number05352894190
Lot NumberP09467
Device Expiration Date2012-08-31
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2012-04-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.